August 13, 2019 / 1:48 AM / 4 months ago

Sanofi seeks billions from Mylan in EpiPen antitrust lawsuit

Sanofi SA wants Mylan PLC to pay up to $11.7 billion in damages for engaging in a scheme to squelch competition to its EpiPen allergy treatment, which became the center of a firestorm over drug price increases.

The French drugmaker detailed its damages claim on Friday as it urged a federal judge in Kansas City, Kansas, to allow it to proceed with a lawsuit alleging Mylan took actions to crush the competitive threat posed by Sanofi’s newer product, Auvi-Q.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below